{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:42:50Z","timestamp":1791420170513,"version":"4.3.3"},"reference-count":45,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,7,1]]},"abstract":"<jats:p>Multiple myeloma is a malignancy of plasma cells. Vaccine immunotherapy is among the novel therapeutic strategies under investigation for this disease. To identify myeloma-associated antigens as potential targets for vaccine immunotherapy, we surveyed a comprehensive panel of bone marrow specimens from patients with monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma for expression of cancer-testis (CT) antigens. Immunohistochemistry (IHC) demonstrated that 82% of stage-III myeloma specimens expressed the CT antigen CT7 (also known as melanoma antigen C1 [MAGE-C1]) and 70% expressed MAGE-A3\/6. Messenger RNA for CT7 and MAGE-A family members was detected in 87% and 100% of stage-III samples, respectively. CT7 protein expression increased with advanced stage of disease. Higher levels of CT7 and MAGE-A3\/6 proteins also correlated with elevated plasma-cell proliferation. These results show that CT7 and MAGE-A3\/6 are promising myeloma-associated antigens for application in vaccine immunotherapy. Furthermore, the common expression and correlation with proliferation suggest a possible pathogenic role for these proteins in myeloma.<\/jats:p>","DOI":"10.1182\/blood-2004-12-4931","type":"journal-article","created":{"date-parts":[[2005,3,11]],"date-time":"2005-03-11T02:53:37Z","timestamp":1110509617000},"page":"167-174","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":161,"title":["The cancer-testis antigens CT7 (MAGE-C1) and MAGE-A3\/6 are commonly expressed in multiple myeloma and correlate with plasma-cell proliferation"],"prefix":"10.1182","volume":"106","author":[{"given":"Achim A.","family":"Jungbluth","sequence":"first","affiliation":[{"name":"From the New York Branch, Ludwig Institute for Cancer Research, New York, NY; Department of Pathology, Weill Medical College of Cornell University, New York, NY; Division of Hematology\/Medical Oncology, Department of Medicine, Weill Medical College of Cornell University, New York, NY; Graduate Program in Immunology and Microbial Pathogenesis, Weill Graduate School of Medical Sciences, New York, NY; and the New York University School of Medicine, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Ely","sequence":"additional","affiliation":[{"name":"From the New York Branch, Ludwig Institute for Cancer Research, New York, NY; Department of Pathology, Weill Medical College of Cornell University, New York, NY; Division of Hematology\/Medical Oncology, Department of Medicine, Weill Medical College of Cornell University, New York, NY; Graduate Program in Immunology and Microbial Pathogenesis, Weill Graduate School of Medical Sciences, New York, NY; and the New York University School of Medicine, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"DiLiberto","sequence":"additional","affiliation":[{"name":"From the New York Branch, Ludwig Institute for Cancer Research, New York, NY; Department of Pathology, Weill Medical College of Cornell University, New York, NY; Division of Hematology\/Medical Oncology, Department of Medicine, Weill Medical College of Cornell University, New York, NY; Graduate Program in Immunology and Microbial Pathogenesis, Weill Graduate School of Medical Sciences, New York, NY; and the New York University School of Medicine, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Niesvizky","sequence":"additional","affiliation":[{"name":"From the New York Branch, Ludwig Institute for Cancer Research, New York, NY; Department of Pathology, Weill Medical College of Cornell University, New York, NY; Division of Hematology\/Medical Oncology, Department of Medicine, Weill Medical College of Cornell University, New York, NY; Graduate Program in Immunology and Microbial Pathogenesis, Weill Graduate School of Medical Sciences, New York, NY; and the New York University School of Medicine, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Williamson","sequence":"additional","affiliation":[{"name":"From the New York Branch, Ludwig Institute for Cancer Research, New York, NY; Department of Pathology, Weill Medical College of Cornell University, New York, NY; Division of Hematology\/Medical Oncology, Department of Medicine, Weill Medical College of Cornell University, New York, NY; Graduate Program in Immunology and Microbial Pathogenesis, Weill Graduate School of Medical Sciences, New York, NY; and the New York University School of Medicine, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Frosina","sequence":"additional","affiliation":[{"name":"From the New York Branch, Ludwig Institute for Cancer Research, New York, NY; Department of Pathology, Weill Medical College of Cornell University, New York, NY; Division of Hematology\/Medical Oncology, Department of Medicine, Weill Medical College of Cornell University, New York, NY; Graduate Program in Immunology and Microbial Pathogenesis, Weill Graduate School of Medical Sciences, New York, NY; and the New York University School of Medicine, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Tseng","family":"Chen","sequence":"additional","affiliation":[{"name":"From the New York Branch, Ludwig Institute for Cancer Research, New York, NY; Department of Pathology, Weill Medical College of Cornell University, New York, NY; Division of Hematology\/Medical Oncology, Department of Medicine, Weill Medical College of Cornell University, New York, NY; Graduate Program in Immunology and Microbial Pathogenesis, Weill Graduate School of Medical Sciences, New York, NY; and the New York University School of Medicine, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Bhardwaj","sequence":"additional","affiliation":[{"name":"From the New York Branch, Ludwig Institute for Cancer Research, New York, NY; Department of Pathology, Weill Medical College of Cornell University, New York, NY; Division of Hematology\/Medical Oncology, Department of Medicine, Weill Medical College of Cornell University, New York, NY; Graduate Program in Immunology and Microbial Pathogenesis, Weill Graduate School of Medical Sciences, New York, NY; and the New York University School of Medicine, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selina","family":"Chen-Kiang","sequence":"additional","affiliation":[{"name":"From the New York Branch, Ludwig Institute for Cancer Research, New York, NY; Department of Pathology, Weill Medical College of Cornell University, New York, NY; Division of Hematology\/Medical Oncology, Department of Medicine, Weill Medical College of Cornell University, New York, NY; Graduate Program in Immunology and Microbial Pathogenesis, Weill Graduate School of Medical Sciences, New York, NY; and the New York University School of Medicine, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lloyd J.","family":"Old","sequence":"additional","affiliation":[{"name":"From the New York Branch, Ludwig Institute for Cancer Research, New York, NY; Department of Pathology, Weill Medical College of Cornell University, New York, NY; Division of Hematology\/Medical Oncology, Department of Medicine, Weill Medical College of Cornell University, New York, NY; Graduate Program in Immunology and Microbial Pathogenesis, Weill Graduate School of Medical Sciences, New York, NY; and the New York University School of Medicine, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hearn Jay","family":"Cho","sequence":"additional","affiliation":[{"name":"From the New York Branch, Ludwig Institute for Cancer Research, New York, NY; Department of Pathology, Weill Medical College of Cornell University, New York, NY; Division of Hematology\/Medical Oncology, Department of Medicine, Weill Medical College of Cornell University, New York, NY; Graduate Program in Immunology and Microbial Pathogenesis, Weill Graduate School of Medical Sciences, New York, NY; and the New York University School of Medicine, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021223224298700_REF1","doi-asserted-by":"crossref","unstructured":"Sirohi B, Powles R. Multiple myeloma. Lancet. 2004;363: 875-887.","DOI":"10.1016\/S0140-6736(04)15736-X"},{"key":"2020021223224298700_REF2","doi-asserted-by":"crossref","unstructured":"Drewinko B, Alexanian R, Boyer H, Barlogie B, Rubinow SI. The growth fraction of human myeloma cells. Blood. 1981;57: 333-338.","DOI":"10.1182\/blood.V57.2.333.333"},{"key":"2020021223224298700_REF3","doi-asserted-by":"crossref","unstructured":"Drewinko B, Brown BW, Humphrey R, Alexanian R. Effect of chemotherapy in the labelling index of myeloma cells. Cancer. 1974;34: 526-531.","DOI":"10.1002\/1097-0142(197409)34:3<526::AID-CNCR2820340308>3.0.CO;2-R"},{"key":"2020021223224298700_REF4","doi-asserted-by":"crossref","unstructured":"Knuth A, Wolfel T, Klehmann E, Boon T, Meyer zum Buschenfelde KH. Cytolytic T-cell clones against an autologous human melanoma: specificity study and definition of three antigens by immunoselection. Proc Natl Acad Sci U S A. 1989; 86: 2804-2808.","DOI":"10.1073\/pnas.86.8.2804"},{"key":"2020021223224298700_REF5","doi-asserted-by":"crossref","unstructured":"Scanlan MJ, Gure AO, Jungbluth AA, Old LJ, Chen YT. Cancer\/testis antigens: an expanding family of targets for cancer immunotherapy. Immunol Rev. 2002;188: 22-32.","DOI":"10.1034\/j.1600-065X.2002.18803.x"},{"key":"2020021223224298700_REF6","unstructured":"Banchereau J, Palucka AK, Dhodapkar M, et al. Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine. Cancer Res. 2001; 61: 6451-6458."},{"key":"2020021223224298700_","doi-asserted-by":"crossref","unstructured":"Gnjatic S, Jager E, Chen W, et al. CD8(+) T cell responses against a dominant cryptic HLA-A2 epitope after NY-ESO-1 peptide immunization of cancer patients. Proc Natl Acad Sci U S A. 2002; 99: 11813-11818.","DOI":"10.1073\/pnas.142417699"},{"key":"2020021223224298700_","doi-asserted-by":"crossref","unstructured":"Coulie PG, Karanikas V, Colau D, et al. A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3. Proc Natl Acad Sci U S A. 2001;98: 10290-10295.","DOI":"10.1073\/pnas.161260098"},{"key":"2020021223224298700_REF9","doi-asserted-by":"crossref","unstructured":"Bueler H, Mulligan RC. Induction of antigen-specific tumor immunity by genetic and cellular vaccines against MAGE: enhanced tumor protection by coexpression of granulocyte-macrophage colony-stimulating factor and B7\u20131. Mol Med. 1996;2: 545-555.","DOI":"10.1007\/BF03401639"},{"key":"2020021223224298700_REF10","unstructured":"van Baren N, Brasseur F, Godelaine D, et al. Genes encoding tumor-specific antigens are expressed in human myeloma cells. Blood. 1999; 94: 1156-1164."},{"key":"2020021223224298700_","doi-asserted-by":"crossref","unstructured":"Lim SH, Austin S, Owen-Jones E, Robinson L. Expression of testicular genes in haematological malignancies. Br J Cancer. 1999;81: 1162-1164.","DOI":"10.1038\/sj.bjc.6690824"},{"key":"2020021223224298700_","doi-asserted-by":"crossref","unstructured":"Pellat-Deceunynck C, Mellerin MP, Labarriere N, et al. The cancer germ-line genes MAGE-1, MAGE-3 and PRAME are commonly expressed by human myeloma cells. Eur J Immunol. 2000; 30: 803-809.","DOI":"10.1002\/1521-4141(200003)30:3<803::AID-IMMU803>3.0.CO;2-P"},{"key":"2020021223224298700_","unstructured":"Dhodapkar MV, Osman K, Teruya-Feldstein J, et al. Expression of cancer\/testis (CT) antigens MAGE-A1, MAGE-A3, MAGE-A4, CT-7, and NY-ESO-1 in malignant gammopathies is heterogeneous and correlates with site, stage and risk status of disease. Cancer Immun. 2003;3: 9."},{"key":"2020021223224298700_REF14","doi-asserted-by":"crossref","unstructured":"Lim SH, Bumm K, Chiriva-Intemati M, Xue Y, Wang Z. MAGE-C1 (CT7) gene expression in multiple myeloma: relationship to sperm protein 17. Eur J Haematol. 2001;67: 332-334.","DOI":"10.1034\/j.1600-0609.2001.00552.x"},{"key":"2020021223224298700_REF15","doi-asserted-by":"crossref","unstructured":"Laduron S, Deplus R, Zhou S, et al. MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcription. Nucleic Acids Res. 2004;32: 4340-4350.","DOI":"10.1093\/nar\/gkh735"},{"key":"2020021223224298700_REF16","doi-asserted-by":"crossref","unstructured":"Nagao T, Higashitsuji H, Nonoguchi K, et al. MAGE-A4 interacts with the liver oncoprotein gankyrin and suppresses its tumorigenic activity. J Biol Chem. 2003;278: 10668-10674.","DOI":"10.1074\/jbc.M206104200"},{"key":"2020021223224298700_REF17","doi-asserted-by":"crossref","unstructured":"Tcherpakov M, Bronfman FC, Conticello SG, et al. The p75 neurotrophin receptor interacts with multiple MAGE proteins. J Biol Chem. 2002;277: 49101-49104.","DOI":"10.1074\/jbc.C200533200"},{"key":"2020021223224298700_REF18","doi-asserted-by":"crossref","unstructured":"Salehi AH, Roux PP, Kubu CJ, et al. NRAGE, a novel MAGE protein, interacts with the p75 neurotrophin receptor and facilitates nerve growth factor-dependent apoptosis. Neuron. 2000;27: 279-288.","DOI":"10.1016\/S0896-6273(00)00036-2"},{"key":"2020021223224298700_REF19","doi-asserted-by":"crossref","unstructured":"Klein U, Tu Y, Stolovitzky GA, et al. Transcriptional analysis of the B cell germinal center reaction. Proc Natl Acad Sci U S A. 2003;100: 2639-2644.","DOI":"10.1073\/pnas.0437996100"},{"key":"2020021223224298700_REF20","doi-asserted-by":"crossref","unstructured":"Kyle RA, Therneau TM, Rajkumar SV, et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med. 2002;346: 564-569.","DOI":"10.1056\/NEJMoa01133202"},{"key":"2020021223224298700_REF21","doi-asserted-by":"crossref","unstructured":"Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol. 2003;121: 749-757.","DOI":"10.1046\/j.1365-2141.2003.04355.x"},{"key":"2020021223224298700_REF22","doi-asserted-by":"crossref","unstructured":"Jungbluth AA, Chen YT, Busam KJ, et al. CT7 (MAGE-C1) antigen expression in normal and neoplastic tissues. Int J Cancer. 2002;99: 839-845.","DOI":"10.1002\/ijc.10416"},{"key":"2020021223224298700_REF23","doi-asserted-by":"crossref","unstructured":"Stockert E, Jager E, Chen YT, et al. A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. J Exp Med. 1998;187: 1349-1354.","DOI":"10.1084\/jem.187.8.1349"},{"key":"2020021223224298700_REF24","doi-asserted-by":"crossref","unstructured":"Jungbluth AA, Chen YT, Stockert E, et al. Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues. Int J Cancer. 2001;92: 856-860.","DOI":"10.1002\/ijc.1282"},{"key":"2020021223224298700_REF25","doi-asserted-by":"crossref","unstructured":"Ely SA, Chadburn A, Dayton CM, Cesarman E, Knowles DM. Telomerase activity in B-cell non-Hodgkin lymphoma. Cancer. 2000;89: 445-452.","DOI":"10.1002\/1097-0142(20000715)89:2<445::AID-CNCR33>3.0.CO;2-T"},{"key":"2020021223224298700_REF26","doi-asserted-by":"crossref","unstructured":"Jemal A, Tiwari RC, Murray T, et al. Cancer statistics: 2004. CA Cancer J Clin. 2004;54: 8-29.","DOI":"10.3322\/canjclin.54.1.8"},{"key":"2020021223224298700_REF27","doi-asserted-by":"crossref","unstructured":"Joshua D, Petersen A, Brown R, Pope B, Snowdon L, Gibson J. The labelling index of primitive plasma cells determines the clinical behaviour of patients with myelomatosis. Br J Haematol. 1996; 94: 76-81.","DOI":"10.1046\/j.1365-2141.1996.d01-1784.x"},{"key":"2020021223224298700_REF28","doi-asserted-by":"crossref","unstructured":"Chen YT, Gure AO, Tsang S, et al. Identification of multiple cancer\/testis antigens by allogeneic antibody screening of a melanoma cell line library. Proc Natl Acad Sci U S A. 1998;95: 6919-6923.","DOI":"10.1073\/pnas.95.12.6919"},{"key":"2020021223224298700_REF29","doi-asserted-by":"crossref","unstructured":"Jungbluth AA, Antonescu CR, Busam KJ, et al. Monophasic and biphasic synovial sarcomas abundantly express cancer\/testis antigen NY-ESO-1 but not MAGE-A1 or CT7. Int J Cancer. 2001;94: 252-256.","DOI":"10.1002\/ijc.1451"},{"key":"2020021223224298700_REF30","doi-asserted-by":"crossref","unstructured":"Fonseca R, Barlogie B, Bataille R, et al. Genetics and cytogenetics of multiple myeloma: a workshop report. Cancer Res. 2004;64: 1546-1558.","DOI":"10.1158\/0008-5472.CAN-03-2876"},{"key":"2020021223224298700_REF31","doi-asserted-by":"crossref","unstructured":"Bergsagel PL, Kuehl WM. Chromosome translocations in multiple myeloma. Oncogene. 2001;20: 5611-5622.","DOI":"10.1038\/sj.onc.1204641"},{"key":"2020021223224298700_REF32","unstructured":"Czuchlewski D, Jungbluth A, Chen Y, Cho H, Knowles D, Ely S. Cancer-testis antigens (CTs) are associated with proliferation in MGUS and myeloma but are not expressed by lymphocytes or non-Hodgkin lymphomas [abstract]. United States and Canadian Academy of Pathology meeting, March 2, 2005. Mod Pathol200518(Suppl): 227A."},{"key":"2020021223224298700_REF33","doi-asserted-by":"crossref","unstructured":"Jacobson JL, Hussein MA, Barlogie B, Durie BG, Crowley JJ. A new staging system for multiple myeloma patients based on the Southwest Oncology Group (SWOG) experience. Br J Haematol. 2003;122: 441-450.","DOI":"10.1046\/j.1365-2141.2003.04456.x"},{"key":"2020021223224298700_REF34","unstructured":"Richardson PGG, Barlogie B, Berenson JR, et al. Prognostic factors associated with response in patients with relapsed and refractory multiple myeloma (MM) treated with bortezomib. Paper presented at Annual Meeting of the American Society of Clinical Oncology, May 31, 2003. Chicago, IL."},{"key":"2020021223224298700_REF35","doi-asserted-by":"crossref","unstructured":"Bataille R, Robillard N, Pellat-Deceunynck C, Amiot M. A cellular model for myeloma cell growth and maturation based on an intraclonal CD45 hierarchy. Immunol Rev. 2003;194: 105-111.","DOI":"10.1034\/j.1600-065X.2003.00039.x"},{"key":"2020021223224298700_REF36","doi-asserted-by":"crossref","unstructured":"Houde C, Li Y, Song L, et al. Overexpression of the NOTCH ligand JAG2 in malignant plasma cells from multiple myeloma patients and cell lines. Blood. 2004;104: 3697-3704.","DOI":"10.1182\/blood-2003-12-4114"},{"key":"2020021223224298700_","doi-asserted-by":"crossref","unstructured":"Nefedova Y, Cheng P, Alsina M, Dalton WS, Gabrilovich DI. Involvement of Notch-1 signaling in bone marrow stroma-mediated de novo drug resistance of myeloma and other malignant lymphoid cell lines. Blood. 2004;103: 3503-3510.","DOI":"10.1182\/blood-2003-07-2340"},{"key":"2020021223224298700_REF38","doi-asserted-by":"crossref","unstructured":"Jundt F, Probsting KS, Anagnostopoulos I, et al. Jagged1-induced Notch signaling drives proliferation of multiple myeloma cells. Blood. 2004;103: 3511-3515.","DOI":"10.1182\/blood-2003-07-2254"},{"key":"2020021223224298700_REF39","doi-asserted-by":"crossref","unstructured":"Matsui W, Huff CA, Wang Q, et al. Characterization of clonogenic multiple myeloma cells. Blood. 2004;103: 2332-2336.","DOI":"10.1182\/blood-2003-09-3064"},{"key":"2020021223224298700_REF40","doi-asserted-by":"crossref","unstructured":"Imai Y, Shichijo S, Yamada A, Katayama T, Yano H, Itoh K. Sequence analysis of the MAGE gene family encoding human tumor-rejection antigens. Gene. 1995;160: 287-290.","DOI":"10.1016\/0378-1119(94)00680-Q"},{"key":"2020021223224298700_REF41","unstructured":"Kocher T, Schultz-Thater E, Gudat F, et al. Identification and intracellular location of MAGE-3 gene product. Cancer Res. 1995;55: 2236-2239."},{"key":"2020021223224298700_REF42","doi-asserted-by":"crossref","unstructured":"Rimoldi D, Salvi S, Schultz-Thater E, Spagnoli GC, Cerottini JC. Anti-MAGE-3 antibody 57B and anti-MAGE-1 antibody 6C1 can be used to study different proteins of the MAGE-A family. Int J Cancer. 2000;86: 749-751.","DOI":"10.1002\/(SICI)1097-0215(20000601)86:5<749::AID-IJC24>3.0.CO;2-O"},{"key":"2020021223224298700_REF43","doi-asserted-by":"crossref","unstructured":"Landry C, Brasseur F, Spagnoli GC, et al. Monoclonal antibody 57B stains tumor tissues that express gene MAGE-A4. Int J Cancer. 2000;86: 835-841.","DOI":"10.1002\/(SICI)1097-0215(20000615)86:6<835::AID-IJC12>3.0.CO;2-N"},{"key":"2020021223224298700_REF44","doi-asserted-by":"crossref","unstructured":"Cho HJ, Takabayashi K, Cheng PM, et al. Immunostimulatory DNA -based vaccines induce cytotoxic lymphocyte activity by a T-helper cell-independent mechanism. Nat Biotechnol. 2000;18: 509-514.","DOI":"10.1038\/75365"},{"key":"2020021223224298700_REF45","doi-asserted-by":"crossref","unstructured":"Dhodapkar MV, Bhardwaj N. Active immunization of humans with dendritic cells. J Clin Immunol. 2000;20: 167-174.","DOI":"10.1023\/A:1006681312249"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/106\/1\/167\/1710391\/zh801305000167.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/106\/1\/167\/1710391\/zh801305000167.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T08:33:49Z","timestamp":1586162029000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/106\/1\/167\/103148\/The-cancertestis-antigens-CT7-MAGEC1-and-MAGEA36"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,7,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2004-12-4931","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7,1]]}}}